Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 11, Issue 8 (2022)

Mean performance of different bitter gourd genotypes for various growth and yield characters

Author(s):
K Rajendar Sagar, B Ramesh Babu, M Ravindra Babu and M Paratpara Rao
Abstract:
An investigation is carried out at the College of Horticulture, Dr. Y.S.R Horticulture University, Venkataramannagudem (AP), during rabi season of 2021-22, to evaluate thirty-six genotypes of bitter gourd for various growth and yield traits. The experiment is conducted in RBD model and replicated thrice. Analysis of variance showed highly significant variations among the genotypes for all the growth and yield traits under study. Two genotypes VBGC-7 (25.75), VBGC-24 (30.00) were recorded higher number of fruits per plant than check variety Arka Harit (18.75). Among thirty- six genotypes, three genotypes were recorded with average fruit weight of above 70 g viz., VBGC-21 (74.00), VBGC-22 (87.25), VBGC-23 (70.75) compared to check variety Arka Harit (51.84 g). One genotype VBGC-22 (17.63 cm) recorded higher fruit length than Check variety Arka Harit (13.25 cm). Two genotypes VBGC-12 (15.25), VBGC-27(15.75) were recorded higher number of seeds per fruit than Check variety Arka Harit (12.75). Among thirty-six genotypes twenty two genotypes (VBGC-5 to 7, VBGC-9 to VBGC-13, VBGC-15, VBGC-18, VBGC-19 to VBGC-23, VBGC-24, VBGC-26 to 28, VBGC-30 to VBGC-35) recorded significantly higher number of primary branches per vine than Check Variety Arka Harit (8.82). Sixteen genotypes (VBGC-1 to 3, VBGC-6, VBGC-11, VBGC-12, VBGC-15, VBGC-19, VBGC-20 to 22, VBGC-24, VBGC-25, VBGC-27, VBGC-30, VBGC-31) recorded higher inter nodal length than Check Variety Arka Harit (5.95 cm).
Pages: 1241-1246  |  355 Views  199 Downloads


The Pharma Innovation Journal
How to cite this article:
K Rajendar Sagar, B Ramesh Babu, M Ravindra Babu, M Paratpara Rao. Mean performance of different bitter gourd genotypes for various growth and yield characters. Pharma Innovation 2022;11(8):1241-1246.

Call for book chapter